Renaissance Technologies - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 273 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$49,982
-12.8%
3,230,900
-11.5%
0.08%
+2.4%
Q2 2023$57,341
+17.0%
3,650,000
+22.8%
0.08%
+27.7%
Q1 2023$49,002
+9.7%
2,973,400
+3.8%
0.06%
+6.6%
Q4 2022$44,685
-99.9%
2,864,400
+0.5%
0.06%
+17.3%
Q3 2022$36,953,000
-6.9%
2,849,100
+0.7%
0.05%
+10.6%
Q2 2022$39,709,000
+39.1%
2,828,300
+41.9%
0.05%
+42.4%
Q1 2022$28,543,000
+21.8%
1,993,200
+16.0%
0.03%
+13.8%
Q4 2021$23,427,000
-33.7%
1,718,800
-20.3%
0.03%
-37.0%
Q3 2021$35,330,000
-8.6%
2,156,900
-6.1%
0.05%
-4.2%
Q2 2021$38,659,000
-38.4%
2,297,000
-33.1%
0.05%
-38.5%
Q1 2021$62,716,000
-38.2%
3,434,600
-38.4%
0.08%
-29.1%
Q4 2020$101,532,000
-0.8%
5,578,700
-2.8%
0.11%
+7.8%
Q3 2020$102,343,000
+1.8%
5,736,707
+2.3%
0.10%
+17.2%
Q2 2020$100,546,000
+76.0%
5,607,700
+49.0%
0.09%
+58.2%
Q1 2020$57,128,000
+44.2%
3,763,400
+87.4%
0.06%
+83.3%
Q4 2019$39,622,000
+35.2%
2,008,189
+17.8%
0.03%
+20.0%
Q3 2019$29,316,000
+114.0%
1,704,400
+120.3%
0.02%
+108.3%
Q2 2019$13,696,000773,8000.01%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q3 2022
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,903,662$29,449,6525.37%
MANAGED ASSET PORTFOLIOS, LLC 1,736,416$26,862,3564.12%
Y.D. More Investments Ltd 1,381,550$21,372,5794.11%
Clean Yield Group 533,157$8,167,9653.62%
XY Capital Ltd 143,697$2,222,9931.28%
Mondrian Investment Partners LTD 4,081,715$61,225,7251.26%
Capricorn Fund Managers Ltd 204,892$3,169,6791.10%
Legacy Wealth Asset Management, LLC 124,967$1,933,2390.71%
HAP Trading, LLC 263,679$4,079,1140.65%
BRANDES INVESTMENT PARTNERS, LP 1,802,036$27,877,4930.54%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders